1. Home
  2. TBPH vs VLRS Comparison

TBPH vs VLRS Comparison

Compare TBPH & VLRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBPH
  • VLRS
  • Stock Information
  • Founded
  • TBPH 2013
  • VLRS 2005
  • Country
  • TBPH United States
  • VLRS Mexico
  • Employees
  • TBPH N/A
  • VLRS 6901
  • Industry
  • TBPH Biotechnology: Pharmaceutical Preparations
  • VLRS Air Freight/Delivery Services
  • Sector
  • TBPH Health Care
  • VLRS Consumer Discretionary
  • Exchange
  • TBPH Nasdaq
  • VLRS Nasdaq
  • Market Cap
  • TBPH 464.5M
  • VLRS 525.6M
  • IPO Year
  • TBPH N/A
  • VLRS N/A
  • Fundamental
  • Price
  • TBPH $10.77
  • VLRS $4.80
  • Analyst Decision
  • TBPH Buy
  • VLRS Strong Buy
  • Analyst Count
  • TBPH 3
  • VLRS 5
  • Target Price
  • TBPH $11.33
  • VLRS $8.30
  • AVG Volume (30 Days)
  • TBPH 379.4K
  • VLRS 1.3M
  • Earning Date
  • TBPH 05-08-2025
  • VLRS 07-21-2025
  • Dividend Yield
  • TBPH N/A
  • VLRS N/A
  • EPS Growth
  • TBPH N/A
  • VLRS N/A
  • EPS
  • TBPH N/A
  • VLRS 0.04
  • Revenue
  • TBPH $65,266,000.00
  • VLRS $3,052,207,000.00
  • Revenue This Year
  • TBPH $51.09
  • VLRS $2.04
  • Revenue Next Year
  • TBPH N/A
  • VLRS $12.38
  • P/E Ratio
  • TBPH N/A
  • VLRS $13.27
  • Revenue Growth
  • TBPH 6.11
  • VLRS N/A
  • 52 Week Low
  • TBPH $7.44
  • VLRS $3.49
  • 52 Week High
  • TBPH $11.82
  • VLRS $9.00
  • Technical
  • Relative Strength Index (RSI)
  • TBPH 64.32
  • VLRS 60.98
  • Support Level
  • TBPH $9.10
  • VLRS $4.56
  • Resistance Level
  • TBPH $11.82
  • VLRS $4.83
  • Average True Range (ATR)
  • TBPH 0.39
  • VLRS 0.15
  • MACD
  • TBPH 0.19
  • VLRS 0.08
  • Stochastic Oscillator
  • TBPH 62.23
  • VLRS 94.85

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About VLRS Controladora Vuela Compania de Aviacion S.A.B. de C.V.

Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).

Share on Social Networks: